Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
argenx SE American Depositary Shares · Now $836.09
+4.8% in 7d after detection
Post-detection moves
1h
—
1d
+0.8%
3d
+1.1%
7d
+4.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS